BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2015
View Archived Issues
Chimeric oncolytic adenovirus improves shRNA delivery and tumor growth inhibiton
Read More
Collaborative research agreement signed for the development of antibody drug seeds
Read More
Prana Biotechnology's PBT-2 receives E.U. orphan drug designation for Huntington's disease
Read More
Development award to support Celtaxsys' phase II trial of CTX-4430 in cystic fibrosis
Read More
Phase III study of Sustol meets primary endpoint
Read More
MatinasBioPharma's MAT-9001 superior to Vascepa in reducing blood lipid levels
Read More
Results from an ongoing phase I study of DCR-M1711
Read More
Stemline Therapeutics releases topline results from lead-in stage of pivotal trial for SL-401
Read More
Systemic delivery of AAV-IFNb shows efficacy in the treatment of invasive glioblastoma
Read More
Phase I results reported for ulixertinib in advanced solid tumors
Read More
Neurovive discloses results from phase III trial of ciclosporin in STEMI
Read More
OPKO files NDA for Rayaldee for secondary hyperparathyroidism in CKD
Read More
Antisense Therapeutics announces expanded access program for ATL-1102 for MS
Read More
FDA accepts first sBLA for an immuno-oncology regimen
Read More
Genticel reports preclinical results for second-generation HPV vaccine GTL-002
Read More
University Health Network patents TTK inhibitors
Read More
Allergan patents S1P1 receptor agonists
Read More
Collaborative Medicinal Development develops metal complexes
Read More
BASF discloses oligopeptide apoptosis inhibitors
Read More
Tesaro to collaborate with Merck & Co., completes rolapitant bioequivalence study
Read More
MinervaX starts phase I trial of Group B Streptococcus vaccine
Read More
Arch enters R&D collaboration with CURAM
Read More
Phase I results for PQR-309 in advanced solid tumors pave way for phase II trial
Read More
Peregrine and Memorial Sloan Kettering Cancer Center to collaborate on antibody platform
Read More
Gilead submits sNDA for idelalisib plus ofatumumab
Read More
Redx Pharma discovers new antibacterial to combat MRSA
Read More
Meiji's ME-1100 gets FDA QIDP and fast track designations
Read More